Many potential mechanisms have been identified about the role of obesity and diabetes (or hyperglycemia) in the development of endometrial cancer (27), including adipocyte-derived estrogen signaling, insulin resistance, and synergistic interaction of estradiol and insulin signaling, while studies on the link between hypertension or lipid disorders and endometrial cancer were relatively limited. This evidence concerns the gene INS and Hyperglycemia.